Power List 2024: Prof. Kaweh Mansouri Recognized as One of the Most Influential Ophthalmologists Worldwide
The ELZA Institute is proud to announce that Prof. Kaweh Mansouri has been included in The Ophthalmologist’s “Power List” for the third time.
The ELZA Institute is proud to announce that Prof. Kaweh Mansouri has been included in The Ophthalmologist’s “Power List” for the third time.
A recent paper explores the groundbreaking technique of Femto-CAIRS for advanced keratoconus management and visual rehabilitation.
ELZA Specialist Dr Dion Paridaens Elected President of the European Society of Ophthalmic Plastic & Reconstructive Surgery (ESOPRS) in Naples On September 16, 2023, Dr.
Switzerland, particularly Zurich, has been a leader in corneal cross-linking (CXL) research and innovation for over two decades, explained ELZA’s Medical Director, Prof. Farhad Hafezi,
ELZA’s Medical Director, Prof. Farhad Hafezi has returned from Antalya, Turkey, where he gave a lecture entitled “Frontiers in Cross-Linking in Keratoconus” to the delegates of the
It has been quite the debate. Should surgeons drop riboflavin onto the cornea during the UV irradiation part of a corneal cross-linking (CXL) procedure, or
The ELZA team of surgeons and researchers were all in attendance, and today saw Prof. Hafezi give the attending delegates a lecture on “How to treat thin corneas”, where he examined the history of performing corneal cross-linking (CXL) for the treatment of corneal ectasias like keratoconus. He then brought delegates up-to-date on the research that has been performed over the years to improve how thin corneas are cross-linked. Finally, Prof. Hafezi demonstrated the results of the latest thin cornea cross-linking protocol, sub400, developed by ELAZA, which simplifies the process, and can let surgeons, for the first time, cross-link corneas that are as thin as 200 µm.
The ELZA team of surgeons and researchers were all in attendance, and today saw Prof. Hafezi give the attending delegates a lecture on “How to treat thin corneas”, where he examined the history of performing corneal cross-linking (CXL) for the treatment of corneal ectasias like keratoconus. He then brought delegates up-to-date on the research that has been performed over the years to improve how thin corneas are cross-linked. Finally, Prof. Hafezi demonstrated the results of the latest thin cornea cross-linking protocol, sub400, developed by ELAZA, which simplifies the process, and can let surgeons, for the first time, cross-link corneas that are as thin as 200 µm.
The ELZA team of surgeons and researchers were all in attendance, and today saw Prof. Hafezi give the attending delegates a lecture on “How to treat thin corneas”, where he examined the history of performing corneal cross-linking (CXL) for the treatment of corneal ectasias like keratoconus. He then brought delegates up-to-date on the research that has been performed over the years to improve how thin corneas are cross-linked. Finally, Prof. Hafezi demonstrated the results of the latest thin cornea cross-linking protocol, sub400, developed by ELAZA, which simplifies the process, and can let surgeons, for the first time, cross-link corneas that are as thin as 200 µm.
Mantenha-se informado & receba o boletim informativo
You have successfully joined our subscriber list.
Newsletter abonnieren & informiert bleiben
Sie haben sich erfolgreich in unsere Abonnentenliste eingetragen.
Bitte bestätigen Sie Ihr Abonnement, indem Sie auf den Link in der E-Mail klicken, die wir Ihnen gerade geschickt haben.